{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0204","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0204","name":[{"text":"Dose 2 to dose 3 interval is 8 weeks.  Series complete.\nEvaluation_Test_Type: Interval: At Minimum\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks after dose #2, that the dose is considered to be valid. The series is complete."}],"gender":"female","birthDate":"2019-10-29"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0204-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"Hep B, adolescent or pediatric"}]},"patient":{"reference":"Patient/2013-0204"},"date":"2019-12-29T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0204-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"Hep B, adolescent or pediatric"}]},"patient":{"reference":"Patient/2013-0204"},"date":"2020-04-29T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0204-dose3","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"Hep B, adolescent or pediatric"}]},"patient":{"reference":"Patient/2013-0204"},"date":"2020-06-24T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}},{"resource":{"resourceType":"Parameters","parameter":[{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2013-0204"},"recommendation":[{"date":"2020-06-29T00:00:00.000","forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2999-12-31T00:00:00.000"}],"protocol":{"description":"Evaluation_Test_Type: Interval: At Minimum\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks after dose #2, that the dose is considered to be valid. The series is complete.","series":"HepB"}}]}}]},"request":{"method":"PUT","url":"Parameters"}}]}